<DOC>
	<DOCNO>NCT00898781</DOCNO>
	<brief_summary>RATIONALE : Counting number circulate cancer cell sample blood patient metastatic cancer may help doctor find much cancer spread . PURPOSE : This research study look number circulate cancer cell patient metastatic breast cancer , ovarian cancer , colon cancer , pancreatic cancer .</brief_summary>
	<brief_title>Study Circulating Cancer Cells Patients With Metastatic Breast , Ovarian , Colon , Pancreatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To assess frequency circulate tumor cell ( CTCs ) patient metastatic ovarian , breast , pancreatic , colon cancer . - To assess variability number CTCs patient tumor type . - To correlate number CTCs extent tumor burden measure tumor marker , image , number metastatic site proliferation apoptotic marker . OUTLINE : Blood sample collect treatment analyze use molecular detection technique detect circulate cancer cell . Samples assess immunofluorescence marker proliferation survival ( e.g. , EGFR , phosphorylated EGFR , AKT , phosphorylated AKT , cytokeratins , MAPK , Src , FAK ) .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Radiographic marker evidence metastatic ovarian , breast , pancreatic , colon disease Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify No history prior cancer PRIOR CONCURRENT THERAPY : No prior therapy metastatic disease</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>male breast cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>ovarian sarcoma</keyword>
</DOC>